Provided by Tiger Trade Technology Pte. Ltd.

Array Digital Infrastructure Inc.

33.39
-0.2700-0.80%
Post-market: 33.390.00000.00%19:30 EDT
Volume:294.08K
Turnover:9.80M
Market Cap:2.88B
PE:5.40
High:33.68
Open:33.57
Low:32.68
Close:33.66
52wk High:60.82
52wk Low:32.68
Shares:86.38M
Float Shares:15.56M
Volume Ratio:1.32
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):6.19
EPS(LYR):0.5551
ROE:22.68%
ROA:0.02%
PB:2.28
PE(LYR):60.16

Loading ...

Array Digital Infrastructure H1 Pretax Profit USD 686 Million

THOMSON REUTERS
·
Aug 07

Press Release: Array Reports Second Quarter 2026 Results

Dow Jones
·
Aug 07

Alector Reports Second Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
Aug 07

Morgan Stanley Sticks to Their Sell Rating for Array Digital Infrastructure (AD)

TIPRANKS
·
Aug 06

Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026

GlobeNewswire
·
Aug 06

Array Digital Infrastructure Inc Expected to Post Earnings of 62 Cents a Share - Earnings Preview

Reuters
·
Aug 05

A Closer Look at the Latest IPO: Can Zhiyi Bio's Pioneering Live Biotherapeutic Pipeline Unlock Untapped Potential?

Stock News
·
Aug 04

Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026

GlobeNewswire
·
Aug 04

Earning Preview: Array Digital Infrastructure Inc. Q2 revenue is expected to decrease by 94.24%, and institutional views are cautious

Earnings Agent
·
Aug 01

Array Digital Infrastructure Schedules Quarterly Results Conference Call

Reuters
·
Jul 31

Array Digital Infrastructure Inc Expected to Post Earnings of 62 Cents a Share - Earnings Preview

Reuters
·
Jul 30

Incyte says EC approves Opzelura cream for treatment of AD

TIPRANKS
·
Jul 29

FAA proposes to adopt new AD for Boeing planes, to inspect seat installation

TIPRANKS
·
Jul 28

ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease

GlobeNewswire
·
Jul 28

T-mobile US Inc. Stock Advances 5.7%, Outperforms Market

Dow Jones
·
Jul 25

T-mobile US Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 21

T-mobile US Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 17

Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

GlobeNewswire
·
Jul 15

LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment

GlobeNewswire
·
Jul 14

FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease

GlobeNewswire
·
Jul 14